Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_assertion type Assertion NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_head.
- NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_provenance.
- NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_assertion evidence source_evidence_literature NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_provenance.
- NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_assertion SIO_000772 17342071 NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_provenance.
- NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_assertion wasDerivedFrom lhgdn-20090331 NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_provenance.
- NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_assertion wasGeneratedBy ECO_0000203 NP197213.RAVDJ0a37G1KA-JVykof9NFagIyJp6SVC-SL9lmCPqqm0130_provenance.